Home Search

viaskin - search results

If you're not happy with the results, please do another search
AAFA Press Release Regarding ICER Review

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER Review of New...

Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
FARE-ACAAI-AAN Statement

Joint Statement on Peanut Allergy Therapy Review

Organizations representing patients and allergists urge ICER to adopt a more patient-driven approach to assessing immunotherapies for peanut allergy.
OIT

Leading Allergists, Researchers and Food Allergy Advocates to Discuss State of ‘Food Oral Immunotherapy...

The summit intends to address the risks and benefits of OIT, OIT implementation in practice and the gaps in knowledge about OIT to enable physicians to have a better understanding of this therapy and to help patients make fully-informed choices about treatment options.
Infighting

OIT is a Therapy, Not an Ideology

0
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Peanuts

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for Peanut Allergy

0
An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.
Jigsaw Puzzle

Milk and Peanut Clinical Trial Advances

0
Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.
DBV Patch Closeup

DBV Completes Phase III Study of Peanut Patch

0
The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.
Viaskin Peanut

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of 2017

1
The study received higher-than-expected patient demand.
Packaged Foods

Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common Packaged Foods

0
The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.
DBV Patch Closeup

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

0
The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.